Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Brian McNabb, MD
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
218 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Landesklinikum Sankt Pölten
Sankt Pölten, Lower Austria, Austria
- Medizinische Universität Wien
Vienna, State of Vienna, Austria
- Wilhelminenspital Der Stadt Wien
Vienna, State of Vienna, Austria
- Landeskrankenhaus Graz West
Graz, Styria, Austria
- Innsbruck Universitaetsklinik
Innsbruck, Tyrol, Austria
- Allgemeines Krankenhaus Der Stadt Linz
Linz, Upper Austria, Austria
- Ziekenhuis Netwerk Antwerpen Middelheim
Antwerp, Antwerpen, Belgium
- Imelda Ziekenhuis
Bonheiden, Antwerpen, Belgium
- Centre Hospitalier Universitaire Sart Tilman Liège
Liège, Liege, Belgium
- Zol Genk, Campus Saint Jan
Genk, Limburg, Belgium
- Algemeen Ziekenhuis Sint-Jan
Bruges, West-Vlaanderen, Belgium
- Royal Alexandra Hospital
Edmonton, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- New Brunswick Heart Centre
Saint John, New Brunswick, Canada
- Hamilton Health Sciences
Hamilton, Ontario, Canada
- Hamilton Health Sciences, General Site
Hamilton, Ontario, Canada
- Scarborough Cardiology Research Associates
Scarborough Village, Ontario, Canada
- Saint Michael'S Hospital
Toronto, Ontario, Canada
- University Health Network
Toronto, Ontario, Canada
- Centre Hospitalier de L'Universite de Montreal (chum)
Montreal, Quebec, Canada
- Hôpital Du Sacré-Coeur de Montréal
Montreal, Quebec, Canada
- Montreal Heart Institute
Montreal, Quebec, Canada
- Institut Universitaire de Cardiologie Et de Pneumologie de Québec
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
- Karlovarská Krajská Nemocnice A.S.
Karlovy Vary, Carlsbad Region, Czechia
- Krajská Nemocnice Liberec A.S.
Liberec, Liberec Region, Czechia
- Fakultní Nemocnice Brno
Brno, Czechia
- Fakultní Nemocnice U Sv. Anny V Brne
Brno, Czechia
- Fakultní Nemocnice Olomouc
Olomoucký Kraj, Czechia
- Fakultní Nemocnice V Motole
Prague, Czechia
- Fakultní Nemocnice Královské Vinohrady
Prague, Czechia
- Všeobecná Fakultní Nemocnice V Praze
Prague, Czechia
- Centre Hospitalier D'Annecy
Pringy, Auvergne-Rhône-Alpes, France
- Centre Hospitalier D'Arras
Arras, Hauts-de-France, France
- Hôpital Rangueil
Toulouse, Midi-Pyrenees, France
- Hôpital Bichat-Claude Bernard
Paris, Île-de-France Region, France
- Groupe Hospitalier la Pitié Salpêtrière
Paris, France
- Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
- Kerckhoff-Klinik Gmbh
Bad Nauheim, Hesse, Germany
- Asklepios-Kliniken Langen
Langen, Hesse, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2011
- Primary completion
- 28 Feb 2015
- Completion
- 28 Feb 2015
- Last update posted
- 15 Jul 2016
- Registered enrollment
- 2,651
- Registry id
- NCT01442038
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.